Biotechnology
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

$5.3M

Market Cap • 12/20/2024

2017

(7 years)
Founded

2021

(3 years ago)
IPO

NASDAQ

Listing Exchange
Flag of CA

Vancouver

Headquarters • BC